← The Wire
CORTNasdaq
CORCEPT THERAPEUTICS INC
Pharmaceutical Preparations · DE · CIK 1088856
Develops medications to treat severe disorders by modulating the effects of the hormone cortisol
red 8-K · 90d
$8.90B
Market cap
$87.89
Last close
+0.7%
1D
+10.3%
5D
865K
Volume
Price · last 39 sessions+70.3%
May 4L $51.05 · H $87.89Jun 29
175
Total filings
Jun 17, 2026
Last filing
12/31
Fiscal year end
8-KCompany UpdateJun 17, 20268-KCompany UpdateJun 3, 20268-KExecutive Change · Shareholder VoteMay 28, 202610-Q10-QApr 30, 20268-KResults of Operations · Reg FD DisclosureApr 30, 2026DEF 14ADEF 14AApr 17, 20268-KCompany UpdateMar 25, 202610-K10-KFeb 24, 20268-KResults of Operations · Reg FD DisclosureFeb 24, 20268-KCompany UpdateFeb 19, 20268-KCompany UpdateJan 22, 20268-KCompany UpdateDec 31, 202510-Q10-QNov 4, 20258-KResults of Operations · Reg FD DisclosureNov 4, 20258-KAgreement TerminatedOct 14, 20258-KExecutive ChangeOct 6, 20258-KCompany UpdateSep 10, 202510-Q10-QJul 31, 20258-KResults of Operations · Reg FD DisclosureJul 31, 20258-KCompany UpdateJul 14, 20258-KShareholder VoteJun 16, 202510-Q10-QMay 5, 20258-KResults of Operations · Reg FD DisclosureMay 5, 2025DEF 14ADEF 14AApr 25, 20258-KCompany UpdateMar 31, 20258-KCompany UpdateMar 3, 202510-K10-KFeb 26, 20258-KResults of Operations · Reg FD DisclosureFeb 26, 20258-KCompany UpdateDec 30, 202410-Q10-QOct 30, 20248-KResults of Operations · Reg FD DisclosureOct 30, 202410-Q10-QJul 29, 20248-KResults of Operations · Reg FD DisclosureJul 29, 20248-KExecutive Change · Shareholder VoteMay 23, 202410-Q10-QMay 1, 20248-KResults of Operations · Reg FD DisclosureMay 1, 2024DEFA14ADEFA14AApr 18, 20248-KMaterial Agreement · New Debt / ObligationApr 17, 2024DEF 14ADEF 14AApr 10, 202410-K10-KFeb 15, 20248-KResults of Operations · Reg FD DisclosureFeb 15, 20248-KResults of Operations · Company UpdateJan 8, 20248-KCompany UpdateJan 2, 20248-KBylaw AmendmentDec 11, 202310-Q10-QNov 1, 20238-KResults of Operations · Reg FD DisclosureNov 1, 202310-Q10-QAug 2, 20238-KResults of Operations · Reg FD DisclosureAug 2, 20238-KBylaw Amendment · Shareholder VoteMay 24, 2023DEFA14ADEFA14AMay 8, 202310-Q10-QMay 3, 20238-KResults of Operations · Reg FD DisclosureMay 3, 2023DEF 14ADEF 14AApr 14, 202310-K10-KFeb 28, 20238-KResults of Operations · Reg FD DisclosureFeb 28, 20238-KCompany UpdateFeb 13, 2023SC 13GSC 13GJan 20, 20238-KCompany UpdateDec 8, 202210-Q10-QNov 3, 20228-KResults of Operations · Reg FD DisclosureNov 3, 20228-KMaterial AgreementSep 22, 202210-Q10-QAug 4, 20228-KResults of Operations · Reg FD DisclosureAug 3, 20228-KShareholder VoteJun 2, 202210-Q10-QMay 5, 20228-KResults of Operations · Reg FD DisclosureMay 5, 2022DEF 14ADEF 14AApr 25, 202210-K10-KFeb 15, 20228-KResults of Operations · Reg FD DisclosureFeb 15, 2022SC 13GSC 13GFeb 14, 20228-KCompany UpdateDec 8, 202110-K/A10-K/ANov 15, 202110-Q10-QNov 3, 20218-KResults of Operations · Reg FD DisclosureNov 3, 20218-KExecutive Change · Reg FD DisclosureAug 13, 202110-Q10-QJul 29, 20218-KResults of Operations · Reg FD DisclosureJul 29, 20218-KCompany UpdateJun 15, 20218-KExecutive Change · Reg FD DisclosureJun 10, 20218-KShareholder VoteJun 2, 2021
Insider Activity
In the 90 days to Mar 25, 2026: 1 insider bought $3.3M · 2 sold $3.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 25, 2026 | Belanoff Joseph KChief Executive Officer | Sell | 26,198 | $50.07 | $1.3M |
| Mar 20, 2026 | Guyer WilliamChief Development Officer | Sell | 11,767 | $36.01 | $424K |
| Mar 17, 2026 | Baker G Leonard JrDirector | Buy | 75,782 | $33.00 | $2.5M |
| Mar 17, 2026 | Baker G Leonard JrDirector | Buy | 24,218 | $33.56 | $813K |
| Mar 4, 2026 | Guyer WilliamChief Development Officer | Sell | 8,233 | $35.99 | $296K |
| Feb 3, 2026 | Guyer WilliamChief Development Officer | Sell | 20,000 | $40.87 | $817K |
| Jan 6, 2026 | Guyer WilliamChief Development Officer | Sell | 20,000 | $35.18 | $704K |
| Dec 2, 2025 | Guyer WilliamChief Development Officer | Sell | 19,360 | $80.05 | $1.5M |
| Dec 2, 2025 | Guyer WilliamChief Development Officer | Sell | 640 | $80.88 | $52K |
| Dec 1, 2025 | Belanoff Joseph KChief Executive Officer | Sell | 40,000 | $79.77 | $3.2M |
| Dec 1, 2025 | Maduck SeanSee Remarks | Sell | 20,000 | $79.52 | $1.6M |
| Dec 1, 2025 | Lyon Joseph DouglasSee Remarks | Sell | 5,000 | $79.53 | $398K |
| Nov 25, 2025 | Guyer WilliamChief Development Officer | Sell | 4,500 | $80.90 | $364K |
| Nov 25, 2025 | Guyer WilliamChief Development Officer | Sell | 4,500 | $80.90 | $364K |
| Nov 5, 2025 | Belanoff Joseph KChief Executive Officer | Sell | 14,355 | $74.20 | $1.1M |
| Nov 5, 2025 | Guyer WilliamChief Development Officer | Sell | 13,164 | $75.64 | $996K |
| Nov 5, 2025 | Belanoff Joseph KChief Executive Officer | Sell | 10,837 | $75.14 | $814K |
| Nov 5, 2025 | Guyer WilliamChief Development Officer | Sell | 6,536 | $74.75 | $489K |
| Nov 5, 2025 | Belanoff Joseph KChief Executive Officer | Sell | 3,590 | $75.98 | $273K |
| Nov 5, 2025 | Guyer WilliamChief Development Officer | Sell | 300 | $76.28 | $23K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance